Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLUTION trial of losmapimod in COPD with systemic inflammation
2011-004936-75Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of losmapimod in chronic obstructive pulmonary disease (COPD), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoints: Change in vascular inflammation, Change in endothelial function and 1 more. Started May 2012; status: completed.
02
Drugs
losmapimod
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2011-004936-75.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004936-75.